What is US Enzyme?
US Enzyme specializes in the creation of environmentally conscious mold and mycotoxin removal products derived from 100% natural ingredients. Their innovative enzyme-based solutions are designed for safety in both residential and ecological settings, effectively tackling mycotoxins often overlooked in conventional remediation processes. The company serves a broad spectrum of clients, including homeowners, professional remediation services, and healthcare providers, offering premium enzyme supplements and cleaning agents. US Enzymes is recognized by leading mold removal firms for its commitment to delivering potent cleaning power without the use of harsh chemicals.
How much funding has US Enzyme raised?
US Enzyme has raised a total of $13K across 1 funding round:
Debt
$13K
Debt (2021): $13K with participation from PPP
Key Investors in US Enzyme
PPP
Public-Private Partnership
What's next for US Enzyme?
With its Series A/B growth stage funding, US Enzyme is poised for significant expansion. The recent capital injection is expected to fuel advancements in product development, market penetration, and operational scaling. This strategic investment will likely enable the company to broaden its reach, enhance its product portfolio, and solidify its position as a leader in the natural remediation market, addressing growing consumer demand for sustainable and effective cleaning solutions.
See full US Enzyme company page
